[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0950049T3 - Diphenylalkyltetrahydropyridiner, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse - Google Patents

Diphenylalkyltetrahydropyridiner, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0950049T3
DK0950049T3 DK97951326T DK97951326T DK0950049T3 DK 0950049 T3 DK0950049 T3 DK 0950049T3 DK 97951326 T DK97951326 T DK 97951326T DK 97951326 T DK97951326 T DK 97951326T DK 0950049 T3 DK0950049 T3 DK 0950049T3
Authority
DK
Denmark
Prior art keywords
pct
preparation
pharmaceutical compositions
compositions containing
diphenylalkyltetrahydropyridines
Prior art date
Application number
DK97951326T
Other languages
English (en)
Inventor
Marco Baroni
Rosanna Cardamone
Jacqueline Fournier
Umberto Guzzi
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK0950049T3 publication Critical patent/DK0950049T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97951326T 1996-12-13 1997-12-12 Diphenylalkyltetrahydropyridiner, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse DK0950049T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615336A FR2757161B1 (fr) 1996-12-13 1996-12-13 Diphenylalkyl-tetrahydropyridines
PCT/FR1997/002289 WO1998025904A1 (fr) 1996-12-13 1997-12-12 Diphenylalkyl-tetrahydropyridines, procede pour leur preparation et composition pharmaceutique les contenant

Publications (1)

Publication Number Publication Date
DK0950049T3 true DK0950049T3 (da) 2002-01-28

Family

ID=9498642

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97951326T DK0950049T3 (da) 1996-12-13 1997-12-12 Diphenylalkyltetrahydropyridiner, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse

Country Status (31)

Country Link
US (1) US6124318A (da)
EP (1) EP0950049B1 (da)
JP (1) JP2001505903A (da)
KR (1) KR100549656B1 (da)
CN (1) CN1144784C (da)
AT (1) ATE207056T1 (da)
AU (1) AU730142B2 (da)
BR (1) BR9713926A (da)
CA (1) CA2274946C (da)
CY (1) CY2282B1 (da)
CZ (1) CZ290242B6 (da)
DE (1) DE69707504T2 (da)
DK (1) DK0950049T3 (da)
EE (1) EE03764B1 (da)
ES (1) ES2167805T3 (da)
FR (1) FR2757161B1 (da)
HK (1) HK1024001A1 (da)
HU (1) HUP0001437A3 (da)
IL (2) IL130001A0 (da)
IS (1) IS2001B (da)
NO (1) NO313282B1 (da)
NZ (1) NZ336032A (da)
PL (1) PL192926B1 (da)
PT (1) PT950049E (da)
RS (1) RS49672B (da)
RU (1) RU2198874C2 (da)
SI (1) SI0950049T1 (da)
SK (1) SK283332B6 (da)
TR (1) TR199901290T2 (da)
UA (1) UA52708C2 (da)
WO (1) WO1998025904A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
CA2404858A1 (en) * 2000-04-12 2001-10-25 Minerva Biotechnologies Corporation Treatment of neurodegenerative disease
US6699866B2 (en) 2001-04-17 2004-03-02 Sepracor Inc. Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
EP1763337A2 (en) * 2003-12-31 2007-03-21 Actavis Group HF Immediate, controlled and sustained release formulations of galanthamine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1321701A (en) * 1969-10-01 1973-06-27 Continental Pharma Amino-alcohols their salts and process for prepairing the same
BE775611A (fr) * 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
US5266573A (en) * 1989-08-07 1993-11-30 Elf Sanofi Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser

Also Published As

Publication number Publication date
HK1024001A1 (en) 2000-09-29
IS2001B (is) 2005-04-15
EP0950049A1 (fr) 1999-10-20
SI0950049T1 (en) 2002-10-31
IL130001A (en) 2006-04-10
FR2757161A1 (fr) 1998-06-19
EE03764B1 (et) 2002-06-17
CN1144784C (zh) 2004-04-07
UA52708C2 (uk) 2003-01-15
PT950049E (pt) 2002-03-28
DE69707504T2 (de) 2002-06-27
NZ336032A (en) 2000-12-22
ES2167805T3 (es) 2002-05-16
US6124318A (en) 2000-09-26
SK283332B6 (sk) 2003-06-03
WO1998025904A1 (fr) 1998-06-18
PL192926B1 (pl) 2006-12-29
KR100549656B1 (ko) 2006-02-08
HUP0001437A3 (en) 2001-12-28
ATE207056T1 (de) 2001-11-15
EP0950049B1 (fr) 2001-10-17
RU2198874C2 (ru) 2003-02-20
NO313282B1 (no) 2002-09-09
IS5074A (is) 1999-06-10
DE69707504D1 (de) 2001-11-22
CA2274946C (en) 2005-09-20
RS49672B (sr) 2007-11-15
YU26399A (sh) 2000-03-21
FR2757161B1 (fr) 1999-03-12
JP2001505903A (ja) 2001-05-08
CN1240428A (zh) 2000-01-05
EE9900238A (et) 1999-12-15
CY2282B1 (en) 2003-07-04
AU5489598A (en) 1998-07-03
CA2274946A1 (en) 1998-06-18
TR199901290T2 (xx) 1999-08-23
KR20000069421A (ko) 2000-11-25
AU730142B2 (en) 2001-03-01
NO992870D0 (no) 1999-06-11
SK78799A3 (en) 1999-12-10
CZ211099A3 (cs) 1999-09-15
CZ290242B6 (cs) 2002-06-12
PL334073A1 (en) 2000-01-31
NO992870L (no) 1999-08-11
HUP0001437A2 (hu) 2000-09-28
IL130001A0 (en) 2000-02-29
BR9713926A (pt) 2000-03-21

Similar Documents

Publication Publication Date Title
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
DK0876350T3 (da) Pyrazolderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
DK0766696T3 (da) Thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse forbindelser
DK0950049T3 (da) Diphenylalkyltetrahydropyridiner, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse
HUP9801133A2 (hu) 1,2,4-Triazol-származékok, továbbá ilyen vegyületeket hatóanyagként tartalmazó fungicid készítmények
FI956300A (fi) Pyridatsinonijohdannaisia
DK0847384T3 (da) Carbamoylcarboxylsyreamider
WO2000020399A3 (de) Verwendung von substituierten 5-hydroxypyrazolen, neue 5-hydroxypyrazole, verfahren zu deren herstellung, sowie sie enthaltende mittel
DE59310218D1 (de) Inhibitoren retroviraler proteasen
TH4140A (th) 1-อาริลไพราโซล